vs
SELECT MEDICAL HOLDINGS CORP（SEM）とTapestry, Inc.（TPR）の財務データ比較。上の社名をクリックして会社を切り替えられます
Tapestry, Inc.の直近四半期売上が大きい（$2.5B vs $1.4B、SELECT MEDICAL HOLDINGS CORPの約1.8倍）。Tapestry, Inc.の純利益率が高く（22.4% vs 1.4%、差は21.0%）。Tapestry, Inc.の前年同期比売上増加率が高い（14.0% vs 6.4%）。Tapestry, Inc.の直近四半期フリーキャッシュフローが多い（$1.0B vs $5.2M）。過去8四半期でTapestry, Inc.の売上複合成長率が高い（29.9% vs 2.8%）
セレクト・メディカルはペンシルベニア州を拠点とする医療企業で、長期急性期ケアや入院リハビリテーション病院を運営するほか、職業健康クリニックや理学療法クリニックも展開している。親会社のセレクト・メディカル・ホールディングスはニューヨーク証券取引所に上場している。
Tapestry, Inc.はアメリカ発の大手多国籍ラグジュアリーファッション持株会社で、Coach、Kate Spade New York、Stuart Weitzmanの3つの代表的なライフスタイルブランドを保有し、高級ハンドバッグ、アパレル、靴、アクセサリー、香水などを世界中の消費者に提供しています。
SEM vs TPR — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.4B | $2.5B |
| 純利益 | $20.2M | $561.3M |
| 粗利率 | — | 75.5% |
| 営業利益率 | 4.6% | 28.6% |
| 純利益率 | 1.4% | 22.4% |
| 売上前年比 | 6.4% | 14.0% |
| 純利益前年比 | 225.7% | 80.8% |
| EPS（希薄化後） | $0.17 | $2.68 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.4B | $2.5B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.4B | $1.6B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.3B | $1.5B |
| Q4 25 | $20.2M | $561.3M | ||
| Q3 25 | $28.8M | $274.8M | ||
| Q2 25 | $40.6M | $-517.1M | ||
| Q1 25 | $56.7M | $203.3M | ||
| Q4 24 | $-16.1M | $310.4M | ||
| Q3 24 | $55.6M | $186.6M | ||
| Q2 24 | $77.6M | $159.3M | ||
| Q1 24 | $96.9M | $139.4M |
| Q4 25 | — | 75.5% | ||
| Q3 25 | — | 76.3% | ||
| Q2 25 | — | 76.3% | ||
| Q1 25 | — | 76.1% | ||
| Q4 24 | — | 74.4% | ||
| Q3 24 | — | 75.3% | ||
| Q2 24 | — | 74.9% | ||
| Q1 24 | — | 74.7% |
| Q4 25 | 4.6% | 28.6% | ||
| Q3 25 | 5.4% | 19.3% | ||
| Q2 25 | 6.5% | -33.9% | ||
| Q1 25 | 8.3% | 16.0% | ||
| Q4 24 | 1.6% | 22.4% | ||
| Q3 24 | 4.3% | 16.7% | ||
| Q2 24 | 5.8% | 14.8% | ||
| Q1 24 | 9.0% | 13.8% |
| Q4 25 | 1.4% | 22.4% | ||
| Q3 25 | 2.1% | 16.1% | ||
| Q2 25 | 3.0% | -30.0% | ||
| Q1 25 | 4.2% | 12.8% | ||
| Q4 24 | -1.2% | 14.1% | ||
| Q3 24 | 4.4% | 12.4% | ||
| Q2 24 | 6.1% | 10.0% | ||
| Q1 24 | 7.3% | 9.4% |
| Q4 25 | $0.17 | $2.68 | ||
| Q3 25 | $0.23 | $1.28 | ||
| Q2 25 | $0.32 | $-2.30 | ||
| Q1 25 | $0.44 | $0.95 | ||
| Q4 24 | $-0.12 | $1.38 | ||
| Q3 24 | $0.43 | $0.79 | ||
| Q2 24 | $0.60 | $0.67 | ||
| Q1 24 | $0.75 | $0.60 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $26.5M | $1.1B |
| 総負債低いほど良い | $1.8B | $2.4B |
| 株主資本純資産 | $1.7B | $551.2M |
| 総資産 | $5.9B | $6.5B |
| 負債/資本比率低いほどレバレッジが低い | 1.06× | 4.32× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $26.5M | $1.1B | ||
| Q3 25 | $60.1M | $743.2M | ||
| Q2 25 | $52.3M | $1.1B | ||
| Q1 25 | $53.2M | $1.1B | ||
| Q4 24 | $59.7M | $1.0B | ||
| Q3 24 | $191.5M | $7.3B | ||
| Q2 24 | $111.2M | $7.2B | ||
| Q1 24 | $92.6M | $7.4B |
| Q4 25 | $1.8B | $2.4B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.8B | $2.4B | ||
| Q1 25 | $1.8B | $2.4B | ||
| Q4 24 | $1.7B | $2.4B | ||
| Q3 24 | $3.1B | $7.0B | ||
| Q2 24 | $3.6B | $6.9B | ||
| Q1 24 | $3.8B | $7.7B |
| Q4 25 | $1.7B | $551.2M | ||
| Q3 25 | $1.7B | $399.5M | ||
| Q2 25 | $1.7B | $857.8M | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.9B | $3.0B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.4B | $2.8B |
| Q4 25 | $5.9B | $6.5B | ||
| Q3 25 | $5.7B | $6.4B | ||
| Q2 25 | $5.7B | $6.6B | ||
| Q1 25 | $5.7B | $7.3B | ||
| Q4 24 | $5.6B | $7.3B | ||
| Q3 24 | $8.0B | $13.7B | ||
| Q2 24 | $7.9B | $13.4B | ||
| Q1 24 | $7.9B | $13.7B |
| Q4 25 | 1.06× | 4.32× | ||
| Q3 25 | 1.03× | 5.95× | ||
| Q2 25 | 1.10× | 2.77× | ||
| Q1 25 | 1.03× | 1.59× | ||
| Q4 24 | 1.01× | 1.78× | ||
| Q3 24 | 1.62× | 2.35× | ||
| Q2 24 | 2.54× | 2.39× | ||
| Q1 24 | 2.75× | 2.77× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $64.3M | $1.1B |
| フリーキャッシュフロー営業CF - 設備投資 | $5.2M | $1.0B |
| FCFマージンFCF / 売上 | 0.4% | 41.5% |
| 設備投資強度設備投資 / 売上 | 4.2% | 1.7% |
| キャッシュ転換率営業CF / 純利益 | 3.19× | 1.93× |
| 直近12ヶ月FCF直近4四半期 | $117.2M | $1.6B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $64.3M | $1.1B | ||
| Q3 25 | $175.3M | $112.6M | ||
| Q2 25 | $110.3M | $446.8M | ||
| Q1 25 | $-3.5M | $144.3M | ||
| Q4 24 | $125.4M | $506.0M | ||
| Q3 24 | $181.0M | $119.5M | ||
| Q2 24 | $278.2M | $256.0M | ||
| Q1 24 | $-66.7M | $97.8M |
| Q4 25 | $5.2M | $1.0B | ||
| Q3 25 | $122.2M | $80.2M | ||
| Q2 25 | $45.6M | $411.5M | ||
| Q1 25 | $-55.8M | $113.4M | ||
| Q4 24 | $62.0M | $475.1M | ||
| Q3 24 | $130.3M | $93.9M | ||
| Q2 24 | $222.6M | $209.8M | ||
| Q1 24 | $-119.2M | $78.8M |
| Q4 25 | 0.4% | 41.5% | ||
| Q3 25 | 9.0% | 4.7% | ||
| Q2 25 | 3.4% | 23.9% | ||
| Q1 25 | -4.1% | 7.2% | ||
| Q4 24 | 4.7% | 21.6% | ||
| Q3 24 | 10.2% | 6.2% | ||
| Q2 24 | 17.4% | 13.2% | ||
| Q1 24 | -9.0% | 5.3% |
| Q4 25 | 4.2% | 1.7% | ||
| Q3 25 | 3.9% | 1.9% | ||
| Q2 25 | 4.8% | 2.0% | ||
| Q1 25 | 3.9% | 2.0% | ||
| Q4 24 | 4.8% | 1.4% | ||
| Q3 24 | 4.0% | 1.7% | ||
| Q2 24 | 4.3% | 2.9% | ||
| Q1 24 | 4.0% | 1.3% |
| Q4 25 | 3.19× | 1.93× | ||
| Q3 25 | 6.09× | 0.41× | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | -0.06× | 0.71× | ||
| Q4 24 | — | 1.63× | ||
| Q3 24 | 3.25× | 0.64× | ||
| Q2 24 | 3.59× | 1.61× | ||
| Q1 24 | -0.69× | 0.70× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
TPR
| Coach | $1.4B | 57% |
| Other | $787.0M | 31% |
| Kate Spade Company | $290.0M | 12% |
